[Effects of repeated administration of ephedrine and pre-treatment with syrosingopine on the sympathetic ganglia].
D000818:Animals; D001338:Autonomic Fibers, Postganglionic / Q000187:drug effects; D001339:Autonomic Fibers, Preganglionic / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D004246:Dimethylphenylpiperazinium Iodide / Q000037:antagonists & inhibitors; D004285:Dogs; D004558:Electric Stimulation; D004809:Ephedrine / Q000008:administration & dosage* / Q000494:pharmacology; D005725:Ganglia, Autonomic / Q000187:drug effects*; D006584:Hexamethonium Compounds / Q000037:antagonists & inhibitors; D009538:Nicotine / Q000037:antagonists & inhibitors; D011817:Rabbits; D012110:Reserpine / Q000008:administration & dosage* / Q000494:pharmacology; D013757:Tetraethylammonium Compounds / Q000037:antagonists & inhibitors; D014439:Tyramine / Q000494:pharmacology
D006584:Hexamethonium Compounds; D013757:Tetraethylammonium Compounds; D004246:Dimethylphenylpiperazinium Iodide; D009538:Nicotine; D012110:Reserpine; D004809:Ephedrine; D014439:Tyramine